Orris

Oxygen toxicity 5 mark answer for anesthesia university exam

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
I now have comprehensive material from authoritative textbooks. Let me compile a well-structured 5-mark anesthesia exam answer.

Oxygen Toxicity

Definition

Oxygen toxicity refers to the harmful effects of breathing oxygen at elevated partial pressures (hyperoxia) for prolonged periods, resulting in cellular and organ damage - primarily affecting the lungs, central nervous system (CNS), and eyes.

Pathophysiology / Mechanism

The central mechanism is the excessive production of reactive oxygen species (ROS) - specifically:
  • Superoxide anion (O2-) - the primary free radical
  • Hydrogen peroxide (H2O2)
  • Hydroxyl radical (OH-)
At high PO2, the rate of free radical generation overwhelms the cell's natural antioxidant defenses (superoxide dismutase, catalase, glutathione peroxidase, vitamins C and E). The excess free radicals then cause:
  • Lipid peroxidation - membrane dysfunction
  • Protein oxidation - enzyme disruption
  • DNA/nucleic acid damage - mutagenesis and cell death
Goodman & Gilman's Pharmacological Basis of Therapeutics; Fishman's Pulmonary Diseases and Disorders

Types of Oxygen Toxicity

1. Pulmonary Oxygen Toxicity (Lorrain Smith Effect)

  • Most clinically relevant; occurs at FiO2 > 0.5 at 1 ATA with prolonged exposure
  • Subtle pulmonary function changes begin within 8-12 hours of 100% O2
  • Increased capillary permeability within 18 hours
  • Pathological phases:
    • Exudative phase (days 3-4): Death of type I alveolar cells and capillary endothelial cells; interstitial edema; neutrophil infiltration; alveolar exudate
    • Proliferative phase: Type II pneumocyte and endothelial proliferation; fibroblast activity; interstitial scarring
Clinical features:
  • Substernal chest pain (tracheobronchitis) and dry cough
  • Decreased vital capacity and reduced DLCO
  • Decreased lung compliance
  • Ultimately: ARDS; in neonates - hyaline membrane disease / bronchopulmonary dysplasia (BPD)

2. CNS Oxygen Toxicity (Paul Bert Effect)

  • Occurs at high PO2 > 2 ATA (hyperbaric conditions)
  • Clinical features: headache, dizziness, nausea, visual changes (visual field constriction), tinnitus, paresthesias, muscle twitching
  • Convulsions - the most serious manifestation (grand mal seizure)
  • Generally reversible on reduction of PO2

3. Retinal Toxicity

  • Retinopathy of prematurity (ROP): premature neonates exposed to high FiO2 develop abnormal retinal vascularization, risking blindness
  • Myopia and early cataract formation with prolonged hyperbaric O2 therapy
Miller's Anesthesia 10e; Goodman & Gilman's; Fishman's Pulmonary Diseases

Specific Anesthetic Relevance

Absorption Atelectasis

  • When patients are preoxygenated with 100% O2, nitrogen (which stents alveoli open) is washed out
  • Mathematical models show alveolar collapse occurs in 8.7 minutes with 100% O2 pre-oxygenation vs. 37 minutes after air breathing
  • This worsens V/Q mismatch and contributes to post-induction hypoxemia
  • Clinically: using FiO2 0.8 during induction rather than 1.0 reduces atelectasis on CT

Hypercapnia in COPD

  • High FiO2 in chronic CO2 retainers worsens hypercapnia via:
    1. Suppression of hypoxic respiratory drive (classical mechanism)
    2. Haldane effect - O2 displacing CO2 from hemoglobin
    3. V/Q mismatch worsening (release of hypoxic pulmonary vasoconstriction)
    4. Reduced CO2 buffering capacity

Bleomycin Interaction

  • Patients with prior bleomycin chemotherapy are at heightened risk of pulmonary O2 toxicity even with modest FiO2 elevation; residual fibrosis is possible
Miller's Anesthesia 10e; Fishman's Pulmonary Diseases and Disorders

Prevention and Management

ApproachDetail
Keep FiO2 < 0.5 when possiblePulmonary toxicity is generally absent below this threshold
"Air breaks" in hyperbaric therapyIntermittent air breathing slows rate of pulmonary O2 toxicity
Titrate O2 to SpO2 94-98%Avoid unnecessary hyperoxia in all clinical settings
PEEP / lung-protective ventilationReduces atelectasis and minimizes O2 requirement
Antioxidant supplementationVitamin E, vitamin C - experimental/adjunctive
Monitor VC in hyperbaric patients1,425 UPTD units = ~10% decrease in vital capacity
Avoid 100% O2 preoxygenation when safeUse 80% O2 to minimize absorption atelectasis at induction

Key Thresholds to Remember

ParameterValue
Safe FiO2 (long-term)< 0.5 atm (50%)
Pulmonary changes start8-12 hours at 100% O2
CNS toxicity threshold> 2 ATA O2
Neonatal retinal riskAny supplemental O2 in premature infants
UPTD for 10% VC reduction1,425 units
Summary statement for exam: Oxygen toxicity results from ROS overproduction overwhelming antioxidant defenses; it manifests as pulmonary toxicity (tracheobronchitis → ARDS) at normobaric high FiO2, CNS toxicity (convulsions) at hyperbaric pressures, and retinopathy in neonates. In anesthesia, key concerns include absorption atelectasis, COPD-related hypercapnia, and avoiding hyperoxia in bleomycin-exposed patients. The safe threshold for long-term exposure is FiO2 < 0.5.
Sources: Miller's Anesthesia 10e; Fishman's Pulmonary Diseases and Disorders; Goodman & Gilman's Pharmacological Basis of Therapeutics
This is a shared conversation. Sign in to Orris to start your own chat.